ERBB2 and neoplasm: Our IHC analysis also revealed that HER2 level was most remarkably downregulated in the tumor tissues of the co-treated group (Figure 8C–E), along with a significant decrease in the Ki67 level (Figure 8C,D), which indicates a reduced proliferation rate.